So, mobocertinib is this inhibitor that targets the EGFR. It’s used to treat a type of lung cancer, NSCLC, specifically in cases where there are these 20 exon mutations. Its main job is to go after the EGFR and slow down cancer growth.
It comes in 40 mg capsules and you’re supposed to take 160 mg a day, either with or without eating. You’ll find it in bottles, with each one holding 90 capsules.
